Year: 2013
Type: article
Study design: Case Report
Abstract: A patient with rapidly progressive anaplastic thyroid cancer bearing the BRAF V600E mutation has a dramatic response to vemurafenib.
Source: New England Journal of Medicine
DOI: 10.1056/nejmc1215697
Language: English
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
OpenAlex ID: W2078570874